Last month I wrote two articles (here and here) covering some ultra-promising tech stocks that could benefit from the long-term trend from our increased digital world.
Another trend that is likely to be prominent in the future is the provision of health care and associated services.
You might be familiar with our ageing population, more people living longer and the demands that will place on the rest of the population. Well, here are the first four healthcare stocks with potentially huge rosy futures, in no particular order. If not already profitable, they likely will be soon and now might be the perfect time to jump aboard.
Nanosonics Ltd (ASX: NAN) has developed Trophon EPR for disinfecting ultrasound probes, which is much more efficient, healthier and easy to use than traditional methods. Sales recently rose 48%, and Nanosonics reported its first profit as it expands operations in North America and five new countries in Europe. Nanosonics also operates a 'razor and blades' model, selling Trophon systems, as well as consumables for use with the system. That makes for a steady supply of sales.
Somnomed Limited (ASX: SOM) recently reported an 18% increase in revenues, although it also saw a loss of $700,000 as sales and marketing expenses increased, so it's early days for this company. Somnomed has developed oral products (similar to mouthguards) to treat obstructive sleep apnea. Cheaper and less invasive than masks such as those from Resmed Inc (ASX: RMD), the company's products appear to be gathering appeal, and it may not be long before Somnomed is reporting consistent profits.
Pro Medicus Limited (ASX: PME) provides medical imaging software and services to hospitals, imaging centres and health care groups globally. Earlier this week Pro Medicus reported a 42.5% jump in revenues and a huge jump in net profit. The company even paid a dividend – albeit just 1 cent and unfranked – but it's a start. Sales are slowly ramping up, but given the business is software, much of the new revenue should virtually fall through to the bottom line.
ICSGLobal Ltd (ASX: ICS) is another software business, although it primarily supplies medical consultants and specialists with tailored billing services in the UK. Not strictly a health care company, ICS Global also recently invested in education provider OpenLearning. The company expects to report around 50% growth in net profit for the 2015 financial year.
So there you have a quick summary of four stocks, keep an eye out for part two, when I'll unveil the remaining 5 health care stocks with plenty of potential.
